建新股份(300107.SZ):在航空領域的客户為波音、空客等飛機制造商的材料供應商
格隆匯11月20日丨建新股份(300107.SZ)於近期投資者關係活動表示,客户信息屬於公司核心商業祕密。公司產品間氨基苯酚、氯苯碸、氨基碸等產品下游可以應用於複合材料和新材料行業,包括用於聚碸類新材料單體、複合材料固化劑和增韌劑、電子材料固化劑、電子級聚酰亞胺(PI)單體、芳綸中間體、芳碸綸單體等。在航空領域的客户為波音、空客等飛機制造商的材料供應商,目前已經應用到波音、空客飛機的部分機型中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.